Skip to main content
NCBI home page
Journal of Neurology, Neurosurgery, and Psychiatry logoLink to Journal of Neurology, Neurosurgery, and Psychiatry
. 1980 Nov;43(11):971–977. doi: 10.1136/jnnp.43.11.971

Clinical and immunological associations in myasthenia gravis. 2. Cell-mediated immunity.

H J Sagar, G A Davies-Jones, I D Allonby
PMCID: PMC490747  PMID: 6969295

Abstract

Myasthenic patients showed low absolute T cell counts and low spontaneous and phytohaemagglutinin-induced lymphocyte transformation responses. The abnormalities were particularly associated with late onset disease and female sex, but not with HLA phenotype or autoantibody production. Serum factors inhibitory to lymphocyte transformation occurred in some patients.

Full text

PDF
971

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Aarli J. A., Heimann P., Matre R., Thunold S., Tönder O. Lymphocyte subpopulations in thymus and blood from patients with myasthenia gravis. J Neurol Neurosurg Psychiatry. 1979 Jan;42(1):29–34. doi: 10.1136/jnnp.42.1.29. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Abdou N. I., Lisak R. P., Zweiman B., Abrahamsohn I., Penn A. S. The thymus in myasthenia gravis. Evidence for altered cell populations. N Engl J Med. 1974 Dec 12;291(24):1271–1275. doi: 10.1056/NEJM197412122912403. [DOI] [PubMed] [Google Scholar]
  3. Adner M. M., Isé C., Schwab R., Sherman J. D., Dameshek W. Immunologic studies of thymectomized and nonthymectomized patients with myasthenia gravis. Ann N Y Acad Sci. 1966 Jan 26;135(1):536–554. doi: 10.1111/j.1749-6632.1966.tb45501.x. [DOI] [PubMed] [Google Scholar]
  4. Allison A. C., Denman A. M., Barnes R. D. Cooperating and controlling functions of thymus-derived lymphocytes in relation to autoimmunity. Lancet. 1971 Jul 17;2(7716):135–140. doi: 10.1016/s0140-6736(71)92306-3. [DOI] [PubMed] [Google Scholar]
  5. Castleman B. The pathology of the thymus gland in myasthenia gravis. Ann N Y Acad Sci. 1966 Jan 26;135(1):496–505. doi: 10.1111/j.1749-6632.1966.tb45497.x. [DOI] [PubMed] [Google Scholar]
  6. Conti-Tronconi B. M., Morgutti M., Sghirlanzoni A., Clementi F. Cellular immune response against acetylcholine receptor in myasthenia gravis: I. Relevance to clinical course and pathogenesis. Neurology. 1979 Apr;29(4):496–501. doi: 10.1212/wnl.29.4.496. [DOI] [PubMed] [Google Scholar]
  7. Feltkamp T. E., van den Berg-Loonen P. M., Nijenhuis L. E., Engelfriet C. P., van Rossum A. L., van Loghem J. J., Oosterhuis H. J. Myasthenia gravis, autoantibodies, and HL-A antigens. Br Med J. 1974 Jan 26;1(5899):131–133. doi: 10.1136/bmj.1.5899.131. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Fitzgerald M. G. The establishment of a normal human population dose-response curve for lymphocytes cultured with PHA (phytohaemagglutinin). Clin Exp Immunol. 1971 Mar;8(3):421–425. [PMC free article] [PubMed] [Google Scholar]
  9. Goldstein G., Whittingham S. Experimental autoimmune thymitis. An animal model of human myasthenia gravis. Lancet. 1966 Aug 6;2(7458):315–318. doi: 10.1016/s0140-6736(66)92599-2. [DOI] [PubMed] [Google Scholar]
  10. Hammarström L., Smith E., Möller E., Franksson C., Matell G., Von Reis G. Myasthenia gravis: studies on HL-A antigens and lymphocyte subpopulations in patients with myasthenia gravis. Clin Exp Immunol. 1975 Aug;21(2):202–215. [PMC free article] [PubMed] [Google Scholar]
  11. Hard R. C., Jr Hyperimmunoglobulinaemia, T-cell deficiency and plasmacytosis in RFM mice with host versus graft disease induced by the perinatal inoculations (T6XRFM)F1 spleen cells. Clin Exp Immunol. 1975 Nov;22(2):330–340. [PMC free article] [PubMed] [Google Scholar]
  12. Houseley J., Oppenheim J. J. Lymphocyte transformation in thymectomized and nonthymectomized patients with myasthenia gravis. Br Med J. 1967 Jun 10;2(5553):679–681. doi: 10.1136/bmj.2.5553.679. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Huang S. W., Rose J. W., Mayer R. F. Assessment of cellular and humoral immunity of myasthenics. J Neurol Neurosurg Psychiatry. 1977 Nov;40(11):1053–1059. doi: 10.1136/jnnp.40.11.1053. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Junge U., Hoekstra J., Wolfe L., Deinhardt F. Microtechnique for quantitative evaluation of in vitro lymphocyte transformation. Clin Exp Immunol. 1970 Sep;7(3):431–437. [PMC free article] [PubMed] [Google Scholar]
  15. Kalden J. R., Lohmann E., Peter H. H., Hilger C. Antibody-dependent cellular cytotoxicity and B-and T-cell activity in the peripheral blood of myasthenia gravis patients. Ann N Y Acad Sci. 1976;274:421–433. doi: 10.1111/j.1749-6632.1976.tb47703.x. [DOI] [PubMed] [Google Scholar]
  16. Kawanami S., Kanaide A., Itoyama Y., Kuroiwa Y. Lymphocyte function in myasthenia gravis. J Neurol Neurosurg Psychiatry. 1979 Aug;42(8):734–740. doi: 10.1136/jnnp.42.8.734. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Knapp W., Pateisky K. Lymphocytotoxins in myasthenia gravis. Z Immunitatsforsch Exp Klin Immunol. 1972 Dec;144(4):329–334. [PubMed] [Google Scholar]
  18. Lisak R. P., Smiley R., Schotland D. H., Bank W. J., Jr, Santoli D. Abnormalities of T-cell subpopulations in the blood and thymus of patients with myasthenia gravis. J Neurol Sci. 1979 Dec;44(1):69–76. doi: 10.1016/0022-510x(79)90224-7. [DOI] [PubMed] [Google Scholar]
  19. Lisak R. P., Zweiman B. Mitogen and muscle extract induced in vitro proliferative responses in myasthenia gravis, dermatomyositis, and polymyositis. J Neurol Neurosurg Psychiatry. 1975 Jun;38(6):521–524. doi: 10.1136/jnnp.38.6.521. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Lisak R. P., Zweiman B., Phillips S. M. Thymic and peripheral blood T- and B-cell levels in myasthenia gravis. Neurology. 1978 Dec;28(12):1298–1301. doi: 10.1212/wnl.28.12.1298. [DOI] [PubMed] [Google Scholar]
  21. Piantelli M., Lauriola L., Carbone A., Evoli A., Tonali P., Musiani P. Subpopulations of T lymphocytes in myasthenia gravis patients. Clin Exp Immunol. 1979 Apr;36(1):85–89. [PMC free article] [PubMed] [Google Scholar]
  22. Sagar H. J., Allonby I. D. Lymphocyte subpopulations in multiple sclerosis: serial studies and clinical correlations. J Neurol Sci. 1979 Sep;43(1):133–148. doi: 10.1016/0022-510x(79)90078-9. [DOI] [PubMed] [Google Scholar]
  23. Sandilands G. P., Gray K., Cooney A., Anderson J. R., Simpson J. A., Behan P. O. Letter: Rosette tests following thymectomy. Lancet. 1975 Jan 18;1(7899):171–172. doi: 10.1016/s0140-6736(75)91479-8. [DOI] [PubMed] [Google Scholar]
  24. Shirai T., Miyata M., Nakase A., Itoh T. Lymphocyte subpopulation in neoplastic and non-neoplastic thymus and in blood of patients with Myasthenia gravis. Clin Exp Immunol. 1976 Oct;26(1):118–123. [PMC free article] [PubMed] [Google Scholar]
  25. Simpson J. A., Behan P. O., Dick H. M. Studies on the nature of autoimmunity in myasthenia gravis. Evidence for an immunodeficiency type. Ann N Y Acad Sci. 1976;274:382–389. doi: 10.1111/j.1749-6632.1976.tb47699.x. [DOI] [PubMed] [Google Scholar]
  26. Staber F. G., Fink U., Sack W. Letter: B lymphocytes in the thymus of patients with myasthenia gravis. N Engl J Med. 1975 May 8;292(19):1032–1033. [PubMed] [Google Scholar]
  27. Szobor A., Staub M., Szathmáry I., Csuka I., Antoni F. Myasthenia gravis: mitotic activity of thymus-dependent and blood-lymphocytes. Acta Med Acad Sci Hung. 1976;33(1):25–39. [PubMed] [Google Scholar]

Articles from Journal of Neurology, Neurosurgery, and Psychiatry are provided here courtesy of BMJ Publishing Group

RESOURCES